1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

TABLE 2: Univariate analysis of variables related to hyperperfusion phenomenon
Variable Hyperperfusion Group (n = 3) Nonhyperperfusion Group (n = 27) P Value
Age <75 y 3 4 .0086
CVR <20% 3 4 .0086
Pretreatment asymmetry index <75% 2 2 .0394
Variable	Hyperperfusion Group (n = 3)	Nonhyperperfusion Group (n = 27)	P Value
Age <75 y	3	4	.0086
CVR <20%	3	4	.0086
Pretreatment asymmetry index <75%	2	2	.0394